Lixisenatide is a GLP-1 Receptor Agonist for Type 2 Diabetes Mellitus Research
GLP-1 receptor agonists are a class of antidiabetic drugs originally developed for type 2 diabetes. It activates GLP-1 receptors to reduce blood sugar and energy intake, mimicking the effects of…